Scott E. Woodman, Ph.D.

2004 Yeshiva University, New York, NY, United States 
Molecular Biology, Animal Physiology Biology
"Scott Woodman"
Mean distance: 6635.5


Sign in to add mentor
Michael P. Lisanti grad student 2004 Yeshiva University
 (A characterization of caveolins/caveolae in cardiac and smooth muscle tissues.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Gao J, Shi LZ, Zhao H, et al. (2016) Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy. Cell
Chen PL, Roh W, Reuben A, et al. (2016) Analysis of immune signatures in longitudinal tumor samples yields insight into biomarkers of response and mechanisms of resistance to immune checkpoint blockade. Cancer Discovery
Yoo JH, Shi DS, Grossmann AH, et al. (2016) ARF6 Is an Actionable Node that Orchestrates Oncogenic GNAQ Signaling in Uveal Melanoma. Cancer Cell
Johnson DB, Roszik J, Shoushtari AN, et al. (2016) Comparative analysis of the GNAQ, GNA11, SF3B1, and EIF1AX driver mutations in melanoma and across the cancer spectrum. Pigment Cell & Melanoma Research
Roszik J, Wu CJ, Siroy AE, et al. (2016) Somatic Copy Number Alterations at Oncogenic Loci Show Diverse Correlations with Gene Expression. Scientific Reports. 6: 19649
Cooper ZA, Reuben A, Spencer CN, et al. (2016) Distinct clinical patterns and immune infiltrates are observed at time of progression on targeted therapy versus immune checkpoint blockade for melanoma Oncoimmunology. 5
Han L, Diao L, Yu S, et al. (2015) The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers. Cancer Cell
Wilson MA, Zhao F, Khare S, et al. (2015) Copy number changes are associated with response to treatment with carboplatin, paclitaxel, and sorafenib in melanoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Glitza IC, Haymaker C, Bernatchez C, et al. (2015) Intrathecal administration of tumor-infiltrating lymphocytes is well tolerated in a patient with leptomeningeal disease from metastatic melanoma: A case report. Cancer Immunology Research
Capparelli C, Rosenbaum S, Berman-Booty LD, et al. (2015) ErbB3-ErbB2 Complexes as a Therapeutic Target in a Subset of Wild-type BRAF/NRAS Cutaneous Melanomas. Cancer Research. 75: 3554-67
See more...